Učitavanje...

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells

BACKGROUND: Natalizumab is an antibody directed against integrin α4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the CNS. The goal of this study was to characterize the effects of natalizumab treatment on cytokine production and e...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kivisäkk, P, Healy, B C., Viglietta, V, Quintana, F J., Hootstein, M A., Weiner, H L., Khoury, S J.
Format: Artigo
Jezik:Inglês
Izdano: American Academy of Neurology 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2690969/
https://ncbi.nlm.nih.gov/pubmed/19487650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3181a8266f
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!